Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The ...
Q1 2026
May 5, 2026
FY 2025
Mar 10, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 6, 2025
